retatrutide clinical trial data Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide Shines in Obesity Trial

Not a minor dip

Eating smaller meals, avoiding heavy or spicy foods, and staying well-hydrated can help relieve these symptoms

Commonly reported adverse events in trial reports (non-exhaustive) Gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) reported in controlled trials Decreased appetite Safety monitoring included additional endpoints and clinical assessments per protocol Does retatrutide cause hair loss

A review of practical issues on the use of glucagon-like peptide-1 receptor agonists for the management of type 2 diabetes

www.vogue.com By Margaux Anbouba, 2025-08-21 All products featured on Vogue are independently selected by our editors

pylori Breath and Stool Testing